News

IOL Chemicals and Pharmaceuticals Limited informed the National Stock Exchange of India Ltd. and BSE Limited that it received a certificate from M/s. Alankit Assignment Limited, its Registrar and Share Transfer Agent, in compliance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended 30th September 2026.

IOL Chemicals and Pharmaceuticals Limited will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2026, in compliance with SEBI regulations.

Net profit of IOL Chemicals & Pharmaceuticals rose 89.80% to Rs 64.40 crore in the quarter ended June 2026 as against Rs 33.93 crore during the previous quarter ended June 2025. Sales rose 37.08% to Rs 756.26 crore in the quarter ended June 2026 as against Rs 551.69 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales756.26551.69 37 OPM %13.6811.26 - PBDT108.0365.28 65 PBT86.6945.51 90 NP64.4033.93 90 Powered by Capital Market - Live News

IOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 August 2026.

IOL Chemicals & Pharmaceuticals announced that the Annual General Meeting(AGM) of the company will be held on 2 September 2026.